Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Global Forecast 2024-2030
... reach USD 468.61 million in 2024, at a CAGR 4.52% to reach USD 612.00 million by 2030. Global Radioimmunoassays Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Radioimmunoassays Market. It ... Read More
-
Immunofluorescence Assay Market by Products (Antibodies, Consumables & Accessories, Instruments), Type (Direct Immunofluorescence, Indirect Immunofluorescence), Disease, End-User - Global Forecast 2024-2030
... expected to reach USD 4.14 billion in 2024, at a CAGR 5.51% to reach USD 5.80 billion by 2030. Global Immunofluorescence Assay Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Biopharmaceutical Fermentation System Market by Product (Downstream Process Product, Upstream Process Product), Application (Antibiotics, Monoclonal Antibodies, Probiotics), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 16.86 billion in 2024, at a CAGR 7.82% to reach USD 26.52 billion by 2030. Global Biopharmaceutical Fermentation System Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Diagnostic Specialty Antibodies Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), Application (Dengue Diagnostics, Hepatitis Diagnosis, HIV Diagnostics), End User - Global Forecast 2024-2030
... USD 23.11 billion in 2023 and expected to reach USD 24.36 billion in 2024, at a CAGR 5.49% to reach USD 33.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Bioprocess Technology Market by Product (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilar, Monoclonal Antibodies), End-User - Global Forecast 2024-2030
... reach USD 23.70 billion in 2024, at a CAGR 12.39% to reach USD 47.95 billion by 2030. Global Bioprocess Technology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Technology ... Read More
-
Antibody Drug Conjugates Contract Manufacturing Market by Linker (Cleavable, Non-cleavable), Condition (Breast Cancer, Lymphoma, Myeloma), End Use - Global Forecast 2024-2030
... in 2023 and expected to reach USD 13.06 billion in 2024, at a CAGR 11.82% to reach USD 25.99 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antibody ... Read More
-
Antibody Production Market by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies), Process (Downstream Processing, Filtration, Upstream Processing), End-User - Global Forecast 2024-2030
... expected to reach USD 20.16 billion in 2024, at a CAGR 12.40% to reach USD 40.77 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antibody Production Market. It ... Read More
-
Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Global Forecast 2024-2030
... 209.37 billion in 2023 and expected to reach USD 231.55 billion in 2024, at a CAGR 9.30% to reach USD 390.18 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Global Forecast 2024-2030
... at USD 7.34 billion in 2023 and expected to reach USD 7.67 billion in 2024, at a CAGR 9.10% to reach USD 13.51 billion by 2030. Global Oncology Precision Medicine Market FPNV Positioning Matrix The ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Global Forecast 2024-2030
... 6.54 billion in 2023 and expected to reach USD 7.30 billion in 2024, at a CAGR 11.79% to reach USD 14.28 billion by 2030. Global Biologics Contract Development Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 33.12 billion in 2024, at a CAGR 10.57% to reach USD 60.66 billion by 2030. Global Generic Injectables MarketGeneric injectables are non-branded pharmaceuticals that are administered by injection and ... Read More
-
Antibodies Contract Manufacturing Market by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies), Service Type (Analytical Development & Quality Control, Cell Line Development, Process Development), Therapeutic Area, End-User - Global Forecast 202
... size was estimated at USD 14.92 billion in 2023 and expected to reach USD 16.96 billion in 2024, at a CAGR 14.08% to reach USD 37.53 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Cancer Biological Therapy Market by Product (Cancer Growth Blockers, Monoclonal Antibodies, Vaccines), Route of Administration (Intramuscular, Intravenous, Subcutaneous), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 72.42 billion in 2024, at a CAGR 11.60% to reach USD 140.04 billion by 2030. Global Cancer Biological Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Global Forecast 2024-2030
... 8.81 billion in 2023 and expected to reach USD 9.41 billion in 2024, at a CAGR 6.92% to reach USD 14.07 billion by 2030. Global Immunoprotein Diagnostic Testing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Cell Surface Markers Market by Product (Antibodies, PCR Arrays), Source (Mice, Rats), Cell Type, Application, End-User - Global Forecast 2024-2030
... expected to reach USD 858.27 million in 2024, at a CAGR 9.30% to reach USD 1,465.18 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Surface Markers Market. ... Read More
-
Virus Filtration Market by Product (Filtration Systems, Kits & Reagents), Application (Air Purification, Biologicals, Medical Devices), End User - Global Forecast 2024-2030
... and expected to reach USD 2.49 billion in 2024, at a CAGR 14.35% to reach USD 5.60 billion by 2030. Global Virus Filtration Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Global Forecast 2024-2030
... 2023 and expected to reach USD 943.11 million in 2024, at a CAGR 39.62% to reach USD 7,011.84 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the HIV Vaccines ... Read More
-
Biopharmaceutical Processing Equipment & Consumables Market by Product (Bioprocessing Containers, Bioreactors, Biosafety Cabinets), Application (Monoclonal Antibody, Vaccine), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 51.25 billion in 2024, at a CAGR 9.07% to reach USD 86.18 billion by 2030. Global Biopharmaceutical Processing Equipment & Consumables Market FPNV Positioning Matrix The FPNV ... Read More
-
North America, Europe, and Asia-Pacific Large Molecule Bioanalysis Testing Services Market Research Report Forecast to 2030
... demand for high-tech and dependable large molecule bioanalytical testing services, a growing trend of outsourcing laboratory testing services, and an increase in the number of clinical trials. However, the difficulties in developing appropriate analytical techniques ... Read More
-
Anti-vascular Endothelial Growth Factor Therapeutics Market by Therapeutic Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors), Route of Administration (Intravitreal Injections, Oral Administration), Indication - Global Forecast 2024-2030
... estimated at USD 8.49 billion in 2023 and expected to reach USD 9.01 billion in 2024, at a CAGR 8.85% to reach USD 15.38 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Biosimilar Monoclonal Antibodies Market by Drug Class (Abciximab, Adalimumab, Bevacizumab), Application (Diagnostic, Protein Purification, Therapeutic) - Global Forecast 2024-2030
... to reach USD 9.47 billion in 2024, at a CAGR 23.19% to reach USD 33.14 billion by 2030. Global Biosimilar Monoclonal Antibodies Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Global Forecast 2024-2030
... Discovery Outsourcing Market size was estimated at USD 1.60 billion in 2023 and expected to reach USD 1.84 billion in 2024, at a CAGR 15.59% to reach USD 4.41 billion by 2030. Global Cancer Immunotherapy ... Read More
-
Antinuclear Antibody Testing Market by Product (Reagents & Assay Kits, Services, Software), Technique (Enzyme-linked immunosorbent assay (ELISA), Indirect immunofluorescent (IIF), Multiplex immunoassay), Technology, Indication, End-User - Global Forecast
... was estimated at USD 1.77 billion in 2023 and expected to reach USD 1.95 billion in 2024, at a CAGR 10.49% to reach USD 3.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Active Pharmaceutical Ingredients CDMO Market (API-CDMO) by Drug (Generics, Innovative), Product (Antibody Drug Conjugate, Highly Potent Active Pharmaceutical Ingredient, Traditional Active Pharmaceutical Ingredient), Synthesis, Workflow, Application - Gl
... Market size was estimated at USD 114.85 billion in 2023 and expected to reach USD 126.42 billion in 2024, at a CAGR 10.38% to reach USD 229.39 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
Research Assistance
